What is Voxelotor used for?
Voxelotor is used to treat sickle cell disease in adults and children at least 12 years old. Voxelotor is sometimes given together with another medicine called hydroxyurea. Voxelotor was approved by the US Food and Drug Administration (FDA) on an “accelerated” basis.
What is Oxbryta?
Oxbryta works on hemoglobin S to interfere with the first step of the process that causes red blood cells to sickle (polymerization). Because Oxbryta impacts this very first step, it helps to prevent sickling and hemolysis (the breakdown of red blood cells).
Is Voxelotor FDA approved?
The company has introduced Oxbryta® (voxelotor) tablets, the first FDA-approved treatment that directly inhibits sickle hemoglobin polymerization, the root cause of red blood cell sickling in SCD.
How does Voxelotor bind to hemoglobin?
Voxelotor binds irreversibly with the N‐terminal valine of the α‐chain of hemoglobin, leading to an allosteric modification of Hb20, which increases the affinity for oxygen.
How long does Voxelotor take to work?
The median plasma and whole blood Tmax of voxelotor after oral administration is 2 hours. The mean peak concentrations in whole blood and RBCs are observed between 6 and 18 hours after oral administration.
What type of drug is Voxelotor?
Voxelotor is in a class of medications called hemoglobin S (HbS) polymerization inhibitors. It works by helping hemoglobin (a protein in red blood cells) to hold onto more oxygen and to stop red blood cells from becoming misshapen.
What drug class is Oxbryta?
Oxbryta belongs to a drug class called hemoglobin S polymerization inhibitors. (A drug class is a group of medications that work in a similar way.) Oxbryta treats SCD by preventing sickling. Oxbryta comes as a tablet that you swallow.
Can children take Oxbryta?
OXBRYTA is a prescription medicine used for the treatment of sickle cell disease in adults and children 12 years of age and older. It is not known if OXBRYTA is safe and effective in children below 12 years of age.
What class of drug is Voxelotor?
Who makes Voxelotor?
Developed by Global Blood Therapeutics (GBT), the drug is the disease-modifying therapy for targeting the fundamental cause of SCD damage in adults and children of 12 years and older.
Does Voxelotor work as a hemoglobin S polymerization inhibitor?
Voxelotor (Oxbryta) is an HbS polymerization inhibitor that is approved by the U.S. Food & Drug Administration for the treatment of SCD in adults and pediatric patients 12 years and older.
How much does Adakveo cost?
The cost for Adakveo intravenous solution (10 mg/mL) is around $2,507 for a supply of 10 milliliters, depending on the pharmacy you visit….Intravenous Solution.
| Quantity | Per unit | Price |
|---|---|---|
| 10 milliliters | $250.74 | $2,507.41 |